{
  "retracted": false,
  "timestamp": 1531699200000,
  "updates": [
    {
      "timestamp": 1574864730053,
      "identifier": {
        "doi": "10.1007/s00280-018-3641-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-018-3623-7"
  },
  "journal": "Cancer Chemotherapy and Pharmacology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer"
}
